Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway

被引:51
|
作者
Zhang, Wanqiu [1 ,2 ]
Lu, Jinghua [1 ,2 ]
Wang, Yangyang [1 ,2 ,3 ]
Sun, Pengbo [1 ,2 ,3 ]
Gao, Tong [1 ,2 ]
Xu, Naihan [1 ,2 ,3 ]
Zhang, Yaou [1 ,2 ,3 ]
Xie, Weidong [1 ,2 ,3 ]
机构
[1] Tsinghua Univ, Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China
[2] Tsinghua Univ, Inst Biopharmaceut & Hlth Engn, Shenzhen Int Grad Sch, Key Lab Hlth Sci & Technol, Shenzhen 518055, Peoples R China
[3] Tsinghua Univ, Open FIESTA Ctr, Shenzhen Int Grad Sch, Shenzhen 518055, Peoples R China
关键词
canagliflozin; lipotoxicity; cardiomyocytes; inflammation; ferroptosis; AMPK; CARDIOMYOPATHY;
D O I
10.3390/ijms24010858
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic cardiomyopathy (DCM) is a myocardial disease independent of other cardiovascular diseases, such as coronary heart disease, hypertension, etc. Lipotoxicity is closely related to DCM. In this study, we investigated the mechanism of lipid metabolism disturbance in DCM in HL-1 cells. Through bioinformatics and Western blotting analysis, we found that canagliflozin (CAN) significantly inhibited the expression of inflammatory factors cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). Ferroptosis is mediated by lipid peroxidation. We demonstrated the presence of ferroptosis in cardiomyocytes by detecting intracellular Fe2+ content and the levels of reactive oxygen species (ROS), malondialdehyde (MDA), reduced glutathione (GSH), and mitochondrial membrane potential (MMP). CAN could significantly regulate the indicators of ferroptosis. By using specific inhibitors celecoxib (coxib), S-methylisothiourea sulfate (SMT), Ferrostatin-1 (Fer-1), and Compound C, we further found that CAN regulated inflammation and ferroptosis through AMP-activated protein (AMPK), and inflammation interacted with ferroptosis. Our study indicated that CAN attenuated lipotoxicity in cardiomyocytes by regulating inflammation and ferroptosis through activating the AMPK pathway. This study provides a new direction of myocardial lipotoxicity and some new information for the treatment of DCM.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway
    Yang, Jin-yu
    Tao, Li-jun
    Liu, Bei
    You, Xin-yi
    Zhang, Chao-feng
    Xie, Hai-feng
    Li, Ren-shi
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [22] CREG1 Attenuates Doxorubicin-Induced Cardiotoxicity via Inhibiting the Ferroptosis of Cardiomyocytes
    Liu, Dan
    Cheng, Xiaoli
    Song, Haixu
    Yan, Chenghui
    Han, Yaling
    CIRCULATION, 2023, 148
  • [23] Melatonin Attenuates Diabetic Myocardial Microvascular Injury through Activating the AMPK/SIRT1 Signaling Pathway
    Wang, Bin
    Li, Jinyu
    Bao, Mi
    Chen, Runji
    Li, Haiyan
    Lu, Binger
    Chen, Meixin
    Huang, Danmei
    Zhang, Yanmei
    Gao, Fenfei
    Shi, Ganggang
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [24] Ursonic acid attenuates spermatogenesis in oligozoospermia mice through inhibiting ferroptosis
    Dong, Jin
    Dong, Yanli
    Chen, Hanqing
    Ye, Taowen
    Chen, Guangtong
    Fan, Boyi
    Wang, Xiaorong
    Shi, Jianwu
    Wang, Chengniu
    BIOORGANIC CHEMISTRY, 2024, 144
  • [25] Fluorofenidone Attenuates Inflammation by Inhibiting the NF-κB Pathway
    Huang, Ling
    Zhang, Fangfang
    Tang, Yiting
    Qin, Jiao
    Peng, Yu
    Wu, Lin
    Wang, Fang
    Yuan, Qiongjing
    Peng, Zhangzhe
    Liu, Jishi
    Meng, Jie
    Tao, Lijian
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348 (01): : 75 - 80
  • [26] Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction
    Li, Demin
    Zhang, Ge
    Wang, Zeyu
    Guo, Jiacheng
    Liu, Yu
    Lu, Yongzheng
    Qin, Zhen
    Xu, Yanyan
    Cao, Chang
    Wang, Bo
    Guo, Qianqian
    Wang, Yunzhe
    Liu, Guozhen
    Cui, Xiaolin
    Zhang, Jinying
    Tang, Junnan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 943
  • [27] Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway
    Tian, Xue
    Chen, Xu
    Jiang, Qianqian
    Sun, Qianbin
    Liu, Tiantian
    Hong, Yiqin
    Zhang, Yawen
    Jiang, Yanyan
    Shao, Mingyan
    Yang, Ran
    Li, Chun
    Wang, Qiyan
    Wang, Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway
    Zhao, Yingnan
    Li, Yanping
    Liu, Qinhui
    Tang, Qin
    Zhang, Zijing
    Zhang, Jinhang
    Huang, Cuiyuan
    Huang, Hui
    Zhang, Guorong
    Zhou, Jian
    Yan, Jiamin
    Xia, Yan
    Zhang, Zhiyong
    He, Jinhan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2117 - 2128
  • [29] Canagliflozin Regulates Ferroptosis, Potentially via Activating AMPK/PGC-1α/Nrf2 Signaling in HFpEF Rats
    Ma, Sai
    He, Lili
    Zuo, Qingjuan
    Zhang, Guorui
    Guo, Yifang
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2022, 7 (01)
  • [30] Lycopene Ameliorates Polycystic Ovary Syndrome in Rats by Inhibiting Ovarian Ferroptosis Through Activation of the AMPK/Nrf2 Pathway
    Wang, Kexin
    Wang, Lin
    Wu, Chengyong
    Chen, Hongxiang
    Cai, Donghui
    Lu, Linglan
    Liu, Xuli
    Jiao, Zhen
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2025, 39 (02)